{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-040374","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.908284+00:00","generated_at":"2026-06-22T03:29:11.081159+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Nuwellis Q3 revenue $2.1M (+11% YoY); net loss narrows to $3.9M","bullets":["Revenue $2.1M, up 11% from Q3 2021; gross margin 61% vs. 60.4%.","Net loss $3.9M ($0.37 loss/share) vs. $5.3M ($0.75 loss/share) a year ago.","SG&A expenses $4.3M vs. $4.6M; R&D expenses $0.9M vs. $1.7M.","Cash $12.1M at Sep 30; closed $11M public offering on Oct 18, pro-forma cash ~$21.9M.","Activated 3 sites for REVERSE-HF study; awarded U.S. patent for pediatric dialysis innovation."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-040374","json":"https://secwatch.observer/filing/0001140361-22-040374.json","markdown":"https://secwatch.observer/filing/0001140361-22-040374.md","text":"https://secwatch.observer/filing/0001140361-22-040374.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036122040374/0001140361-22-040374-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036122040374/brhc10043820_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T03:29:11.081159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19dc4a85fae90a03a5700b5c822ca1a543844909","claim":"Nuwellis, Inc. reported the three and nine months ended September 30, 2022 results: revenue $2.1 million, net income $3.9 million, EPS $0.37 per basic and diluted common share.","evidence_excerpt":"the lives of people with fluid overload, today reported financial results for the third quarter ended September 30, 2022. Q3 Results and Recent Highlights: • Revenue of $2.1 million in the third quarter 2022, an 11% increase over the same year ago period • Gross margin of 61% was consistent with the same period last year • Activated three additional sites","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506492/000114036122040374/0001140361-22-040374-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2022"},{"label":"Revenue","value":"$2.1 million"},{"label":"Net income","value":"$3.9 million"},{"label":"EPS","value":"$0.37 per basic and diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}